Search results for Carotuximab
Carotuximab Biosimilar – Anti-ENG mAb – Research Grade, ProteoGenix, PX-TA1421
Description of Carotuximab Biosimilar - Anti-ENG mAb - Research Grade General information on Anti-ENG[Homo sapiens] (Carotuximab) Monoclonal Antibody Carotuximab has been investigated for the treatment of Metastatic NSCLC, Recurrent Ovarian, Fallopian Tube, Primary Peritoneal Carcinoma, Advanced Soft Tissue Sarcoma, Hepatocellular Carcinoma, Glioblastoma, Glioblastoma Multiforme, Metastatic Breast Cancer and Advanced Angiosarcoma.
Host
Reactivity
Applications
Conjugation
Carotuximab, Abbexa, abx831378
Carotuximab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ENG, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Host
Human, Mouse
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Carotuximab Biosimilar - Research Grade, ichor.bio, ICH5428
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Carotuximab (HB604016), abinScience, HB604016
Host
Chimeric
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Carotuximab Vedotin Biosimilar - Research Grade, ichor.bio, ICH5428V
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Please provide the required information below so that we can quickly source your products.